Redhill Biopharma
RDHL
#11058
Rank
โ‚น0.45 B
Marketcap
โ‚น51.61
Share price
-6.75%
Change (1 day)
-64.32%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น67,032. In 2017 the company made an earnings per share (EPS) of -โ‚น2,39,400 a decrease over its 2016 EPS that were of -โ‚น2,10,672.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,39,40013.64%
2016-โ‚น2,10,6729.12%
2015-โ‚น1,93,06168.01%
2014-โ‚น1,14,912-25.93%
2013-โ‚น1,55,131

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น182.22-100.27%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น121.19-100.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น306.21-100.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น60.33-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น116.83-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel